164 related articles for article (PubMed ID: 15796199)
1. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells.
Gyémánt N; Tanaka M; Antus S; Hohmann J; Csuka O; Mándoky L; Molnár J
In Vivo; 2005; 19(2):367-74. PubMed ID: 15796199
[TBL] [Abstract][Full Text] [Related]
2. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
3. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
Gyémánt N; Tanaka M; Molnár P; Deli J; Mándoky L; Molnár J
Anticancer Res; 2006; 26(1A):367-74. PubMed ID: 16475720
[TBL] [Abstract][Full Text] [Related]
4. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
Lo YL; Ho CT; Tsai FL
Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
[TBL] [Abstract][Full Text] [Related]
5. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
Ferreira MJ; Gyémánt N; Madureira AM; Tanaka M; Koós K; Didziapetris R; Molnár J
Anticancer Res; 2005; 25(6B):4173-8. PubMed ID: 16309213
[TBL] [Abstract][Full Text] [Related]
6. Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP.
Ugocsai K; Varga A; Molnár P; Antus S; Molnár J
In Vivo; 2005; 19(2):433-8. PubMed ID: 15796208
[TBL] [Abstract][Full Text] [Related]
7. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells.
Duarte N; Járdánházy A; Molnár J; Hilgeroth A; Ferreira MJ
Bioorg Med Chem; 2008 Oct; 16(20):9323-30. PubMed ID: 18824363
[TBL] [Abstract][Full Text] [Related]
9. MDR-reversal activity of chalcones.
Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
[TBL] [Abstract][Full Text] [Related]
10. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
[TBL] [Abstract][Full Text] [Related]
11. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
Tang XQ; Bi H; Feng JQ; Cao JG
Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
[TBL] [Abstract][Full Text] [Related]
12. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines.
Featherstone JM; Speers AG; Lwaleed BA; Hayes MC; Cooper AJ; Birch BR
BJU Int; 2005 May; 95(7):1091-8. PubMed ID: 15839939
[TBL] [Abstract][Full Text] [Related]
13. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
Ji BS; He L
J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
[TBL] [Abstract][Full Text] [Related]
14. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
Lo YL; Wang W
Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
[TBL] [Abstract][Full Text] [Related]
15. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
[TBL] [Abstract][Full Text] [Related]
16. Toxoplasma infection and cell free extract of the parasites are able to reverse multidrug resistance of mouse lymphoma and human gastric cancer cells in vitro.
Varga A; Sokolowska-Kohler W; Presber W; Von Baehr V; Von Baehr R; Lucius R; Volk D; Nacsa J; Hever A
Anticancer Res; 1999; 19(2A):1317-24. PubMed ID: 10368693
[TBL] [Abstract][Full Text] [Related]
17. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
Holland ML; Panetta JA; Hoskins JM; Bebawy M; Roufogalis BD; Allen JD; Arnold JC
Biochem Pharmacol; 2006 Apr; 71(8):1146-54. PubMed ID: 16458258
[TBL] [Abstract][Full Text] [Related]
18. Effect of SILA-409, a new organosilicon multidrug resistance modifier, on human pancreatic cancer xenografts.
Zalatnai A; Molnár J
In Vivo; 2006; 20(1):137-40. PubMed ID: 16433042
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
[TBL] [Abstract][Full Text] [Related]
20. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]